New, shorter drug-resistant tuberculosis (TB) treatment BPaL (comprised of bedaquiline, pretomanid, and linezolid) showed a 94.5 per cent cure rate in countries with a high burden of drug-resistant TB (DR-TB), reveals interim research .
New, shorter drug-resistant tuberculosis (TB) treatment BPaL (comprised of bedaquiline, pretomanid, and linezolid) showed a 94.5 per cent cure rate in countries with a high burden of drug-resistant TB
New, shorter drug-resistant tuberculosis treatment shows promise newkerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newkerala.com Daily Mail and Mail on Sunday newspapers.